Catalyst Wire Dossier Catalyst Wire Dossier

ALN-HSD

· Alnylam Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-HSD, covering 2024-05-17 to 2024-05-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 1]

See pricing